Literature DB >> 24960182

Folk pharmaceutical formulations in western Mediterranean: identification and safety of clays used in pelotherapy.

Rita Sánchez-Espejo1, Carola Aguzzi2, Pilar Cerezo2, Inmaculada Salcedo2, Alberto López-Galindo1, César Viseras3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Clays are naturally occurring ingredients of many natural health products, being included in most of ancient Mediterranean/European medical texts and currently used to prepare therapeutic hot-muds (peloids) in several thermal stations of the Mediterranean region. Clays are included in the formulation of peloids as vehicles of the mineral-medicinal water, to obtain inorganic gels with rheological and thermal properties suitable to be topically applied. Knowledge about formulations and preparation procedures of these traditional medicines has been orally transmitted since ancient times. Increasing recognition of the therapeutic utility of these traditional and natural health care substances make necessary a full ethnopharmaceutic research to ascertain those compositional characters that allow to establish quality attributes and corresponding requirements for these materials and products, including identity, purity, richness and safety.
MATERIALS AND METHODS: Five clay samples (A, B, C, D and E) currently used in various spa centers of southern European/Mediterranean countries were studied. X-Ray diffraction (XRD) and X-ray fluorescence (XRF) data were used to asses sample identity and richness. Elemental impurities and microbiological contaminants were also determined and compared to normative limits. Particle size distribution was related to their safety as powder materials.
RESULTS: Samples A, C, D and E were identified as "high purity clay", while sample B was identified as a mix of clay minerals and carbonates. The presence of carbonates in this sample could compromise its suitability for pelotherapy. The studied clays meet the main normative limits for metals impurities, with the exception of arsenic in sample A and nickel in sample B. The samples comply with the microbiological limits proposed by European legislation for medicinal products. According to the particle size of the studied samples, prevention and control of dust exposure must be considered.
CONCLUSIONS: Despite their demonstrated longevity, the use of clays in traditional medicine formulations as peloids greatly requires comprehension of their identity and safety attributes. Continuity of these mineral substances as recognized health care ingredients oblige to conduct interdisciplinary research to know the features that sustain their traditional use in the preparation of medicines (ethnopharmaceutics).
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Clays; Ethnopharmaceutics; Ethnopharmacy; Natural substances; Pelotherapy; Traditional medicine

Mesh:

Substances:

Year:  2014        PMID: 24960182     DOI: 10.1016/j.jep.2014.06.031

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

Review 1.  Healing and edible clays: a review of basic concepts, benefits and risks.

Authors:  Celso de Sousa Figueiredo Gomes
Journal:  Environ Geochem Health       Date:  2017-02-01       Impact factor: 4.609

2.  Assessment of sapropel use for pharmaceutical products according to legislation, pollution parameters, and concentration of biologically active substances.

Authors:  Ilona Pavlovska; Aneka Klavina; Agris Auce; Ivars Vanadzins; Alise Silova; Laura Komarovska; Baiba Silamikele; Linda Dobkevica; Linda Paegle
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

3.  Traditional knowledge and practice of the Triassic variegated clay from Silesia (Krasiejów), Poland, in human medicine.

Authors:  Izabela Spielvogel; Krzysztof Spałek; Krzysztof Badora; Jarosław Proćków
Journal:  J Ethnobiol Ethnomed       Date:  2021-02-17       Impact factor: 2.733

4.  Evaluation of the Use of Sterilized and Non-Sterilized Peruibe Black Mud in Patients with Knee Osteoarthritis.

Authors:  Paulo Fávio Macedo Gouvêa; Zélia Maria Nogueira Britschka; Cristina de Oliveira Massoco Salles Gomes; Nicolle Gilda Teixeira de Queiroz; Pablo Antonio Vásquez Salvador; Paulo Sergio Cardoso Silva
Journal:  Int J Environ Res Public Health       Date:  2021-02-09       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.